Deutsche Bank’s Aptose Biosciences, Inc. APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-21
Closed -$57K 4882
2021
Q1
$57K Buy
21
+17
+425% +$33.7K ﹤0.01% 4201
2020
Q4
$7K Buy
+4
New +$9.4K ﹤0.01% 4336
2020
Q3
Sell
-242
Closed -$687K 4482
2020
Q2
$687K Buy
+242
New +$781K ﹤0.01% 2449
2020
Q1
Sell
-20
Closed -$59.6K 4271
2019
Q4
$52K Buy
20
+15
+300% +$19.5K ﹤0.01% 3956
2019
Q3
$4K Sell
5
-1
-17% -$1.14K ﹤0.01% 4713
2019
Q2
$7K Sell
6
-3
-33% -$2.76K ﹤0.01% 5050
2019
Q1
$8K Buy
9
+5
+125% +$4.53K ﹤0.01% 4973
2018
Q4
$3K Sell
4
-371
-99% -$365K ﹤0.01% 5047
2018
Q3
$439K Buy
375
+202
+117% +$271K ﹤0.01% 3853
2018
Q2
$307K Sell
173
-64
-27% -$102K ﹤0.01% 4093
2018
Q1
$336K Buy
237
+171
+259% +$229K ﹤0.01% 3935
2017
Q4
$66K Buy
+66
New +$51K ﹤0.01% 4367
2017
Q3
Sell
-1
Closed -$671 5162
2017
Q2
$0 Sell
1
-2
-67% -$963 ﹤0.01% 5185
2017
Q1
$1K Hold
3
﹤0.01% 4840
2016
Q4
$1K Sell
3
-1
-25% -$622 ﹤0.01% 4855
2016
Q3
$4K Buy
4
+2
+100% +$2.08K ﹤0.01% 4785
2016
Q2
$2K Buy
+2
New +$2.36K ﹤0.01% 5100
2016
Q1
Hold
0
5394
2015
Q3
Sell
-11
Closed -$24K 5397
2015
Q2
$24K Buy
11
+2
+22% +$5.23K ﹤0.01% 4863
2015
Q1
$22K Buy
+9
New +$21.7K ﹤0.01% 4638

Other funds holding APTO

Deutsche Bank's APTO Position: Q2 2021 in Review

Deutsche Bank sold out of Aptose Biosciences, Inc. (APTO) in Q2 2021, closing a stake of 21 shares — an estimated $57K sold.

Deutsche Bank first reported a position in APTO in Q1 2015 and held it in 19 quarters. The position peaked at $687K in Q2 2020. 63 funds tracked by Wall St. Rank hold APTO as of Q2 2021.

  • Deutsche Bank reported no remaining Aptose Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 21 Aptose Biosciences, Inc. shares in Q2 2021, an estimated $57K.
  • Deutsche Bank first reported a position in Aptose Biosciences, Inc. in Q1 2015 and held it in 19 quarters.
  • Deutsche Bank's Aptose Biosciences, Inc. position peaked at $687K in Q2 2020.
  • 63 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.